PROVIDER PROFILE · NPI 1154351294

Kendra ZuckermanM.D.

PRACTICEBRYN MAWR MEDICAL SPECIALISTS ASSOCIATIONSee all providers at this practice →
RheumatologyBryn Mawr, PAI
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,306
Unique beneficiaries
—
Total services
32,814
Distinct HCPCS
15
Medicare payment
$583K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 267 Rheumatology providers in PA — top quintile (cohort median 4,116).
PRESCRIBING · PART D · 2024
Total Rx claims
1,322
Beneficiaries
—
Total drug cost
$656K
Distinct drugs
34
Brand share
22.2%
Top prescribed drugs
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$2K
Payment records
114
By payment type
Food and Beverage$2K
Top paying entities
Food and Beverage$2K
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (6)

Hospital
Hospital
Hospital
Hospital
Hospital
Inpatient rehabilitation facility
REFERRAL NETWORK

Where Kendra Zuckerman's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 7 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Norristown, PA
42115
MAIN LINE HOSPITALS, INC.36109
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
2657
MAIN LINE HOSPITALS, INC.1950
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
MAIN LINE HOSPITALS, INC.117403
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Norristown, PA
43122
MAIN LINE HOSPITALS, INC.43153
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA3256
MAIN LINE HOSPITALS, INC.2791
CRESCENDO BIOSCIENCE, INC2347
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
2046
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.